Losartan potassium Tablets, 50 mg
- Product NDC
- 71335-1817
- 11-digit product format
- 713351817
- Labeler code
- 71335
- Product ID
- 71335-1817_fb077532-f94e-44e1-afd3-6be55c4062c8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- losartan potassium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA201170
- Marketing category
- ANDA
- Marketing start
- 2012-09-18
- Substance
- LOSARTAN POTASSIUM
- Active strength
- 50 mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Losartan potassium Tablets, 50 mg
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LOSARTAN POTASSIUM | 50 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 3ST302B24A |
| Rxcui | 979492 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 71335-1817-1 | 2025-10-02 | C162847 | 48780-1 | 1030e365-218d-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995 |
| 71335-1817-2 | 2025-10-02 | C162847 | 48780-1 | 1030e365-218d-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995 |
| 71335-1817-3 | 2025-10-02 | C162847 | 48780-1 | 1030e365-218d-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995 |
| 71335-1817-4 | 2025-10-02 | C162847 | 48780-1 | 1030e365-218d-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995 |
| 71335-1817-5 | 2025-10-02 | C162847 | 48780-1 | 1030e365-218d-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995 |
| 71335-1817-6 | 2025-10-02 | C162847 | 48780-1 | 1030e365-218d-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995 |
| 71335-1817-7 | 2025-10-02 | C162847 | 48780-1 | 1030e365-218d-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995 |
| 71335-1817-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-218d-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995 |
| 71335-1817-2 | 2024-01-30 | C162847 | 48780-1 | 1030e365-218d-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995 |
| 71335-1817-3 | 2024-01-30 | C162847 | 48780-1 | 1030e365-218d-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995 |
| 71335-1817-4 | 2024-01-30 | C162847 | 48780-1 | 1030e365-218d-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995 |
| 71335-1817-5 | 2024-01-30 | C162847 | 48780-1 | 1030e365-218d-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995 |
| 71335-1817-6 | 2024-01-30 | C162847 | 48780-1 | 1030e365-218d-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995 |
| 71335-1817-7 | 2024-01-30 | C162847 | 48780-1 | 1030e365-218d-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71335-1817-1 | Losartan potassium Tablets, 50 mg | 30 in 1 BOTTLE | TABLET | 30 | | 101 |
| 71335-1817-2 | Losartan potassium Tablets, 50 mg | 90 in 1 BOTTLE | TABLET | 90 | | 101 |
| 71335-1817-3 | Losartan potassium Tablets, 50 mg | 60 in 1 BOTTLE | TABLET | 60 | | 101 |
| 71335-1817-4 | Losartan potassium Tablets, 50 mg | 120 in 1 BOTTLE | TABLET | 120 | | 101 |
| 71335-1817-5 | Losartan potassium Tablets, 50 mg | 100 in 1 BOTTLE | TABLET | 100 | | 101 |
| 71335-1817-6 | Losartan potassium Tablets, 50 mg | 180 in 1 BOTTLE | TABLET | 180 | | 101 |
| 71335-1817-7 | Losartan potassium Tablets, 50 mg | 10 in 1 BOTTLE | TABLET | 10 | | 101 |
| 71335-1817-8 | Losartan potassium Tablets, 50 mg | 7 in 1 BOTTLE | TABLET | 7 | | 101 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71335-1817 | LOSARTAN POTASSIUM TABLETS, 50 MG (LOSARTAN POTASSIUM) TABLET [BRYANT RANCH PREPACK] | 100 | Current NDC, Legacy NDC, 8 package rows | 20220106_3d7ddcac-508d-459c-96c8-c62f9c0b5193.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-1817-1 | 71335181701 | 30 TABLET in 1 BOTTLE (71335-1817-1) | 30 tablet | 2021-12-21 | 0000-00-00 | No | No | Current |
| 71335-1817-2 | 71335181702 | 90 TABLET in 1 BOTTLE (71335-1817-2) | 90 tablet | 2021-12-21 | 0000-00-00 | No | No | Current |
| 71335-1817-3 | 71335181703 | 60 TABLET in 1 BOTTLE (71335-1817-3) | 60 tablet | 2021-12-21 | 0000-00-00 | No | No | Current |
| 71335-1817-4 | 71335181704 | 120 TABLET in 1 BOTTLE (71335-1817-4) | 120 tablet | 2021-12-21 | 0000-00-00 | No | No | Current |
| 71335-1817-5 | 71335181705 | 100 TABLET in 1 BOTTLE (71335-1817-5) | 100 tablet | 2021-12-21 | 0000-00-00 | No | No | Current |
| 71335-1817-6 | 71335181706 | 180 TABLET in 1 BOTTLE (71335-1817-6) | 180 tablet | 2021-12-21 | 0000-00-00 | No | No | Current |
| 71335-1817-7 | 71335181707 | 10 TABLET in 1 BOTTLE (71335-1817-7) | 10 tablet | 2021-12-21 | 0000-00-00 | No | No | Current |
| 71335-1817-8 | 71335181708 | 7 TABLET in 1 BOTTLE (71335-1817-8) | 7 tablet | 2021-12-21 | | No | No | Current |